NCT00396175View on ClinicalTrials.gov

Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111)

PHASE3CompletedINTERVENTIONAL
Enrollment

355

Participants

Timeline

Start Date

March 31, 1998

Primary Completion Date

January 31, 2000

Conditions
Androgenetic Alopecia
Interventions
DRUG

MK0906, finasteride / Duration of Treatment : 48 Weeks

DRUG

Comparator : placebo (unspecified) / Duration of Treatment : 48 Weeks

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00396175 - Effects of Finasteride on Serum Prostate-Specific Antigen (0906-111) | Biotech Hunter | Biotech Hunter